Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00085410
Status:
TERMINATED
Last Update Posted:
2017-07-02
First Post:
2004-06-10
Brief Title:
Bortezomib in Treating Patients With Unresectable Locally Advanced or Metastatic Adenocarcinoma of the Bile Duct or Gallbladder
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Unresectable Gallbladder Cancer |
| Adenocarcinoma of the Extrahepatic Bile Duct |
| Adenocarcinoma of the Gallbladder |
| Advanced Adult Primary Liver Cancer |
| Gastrointestinal Cancer |
| Localized Unresectable Adult Primary Liver Cancer |
| Recurrent Adult Primary Liver Cancer |
| Recurrent Extrahepatic Bile Duct Cancer |
| Recurrent Gallbladder Cancer |
| Unresectable Extrahepatic Bile Duct Cancer |
Keywords: